Merck Stock Hits Record High as FDA Approves Its Cardiovascular Disease Drug
Merck & Co. shares soared to a record high Wednesday, a day after the Food and Drug Administration approved the drug maker's treatment for a rare cardiovascular disease.
( 18
min )